Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Machaon Bonafede

Showing results (11-20 of 91) with videos related to

Pageof 10
Sort By:
Journal of Medical Economics|July 2, 2013
Annual acquisition and administration cost of biologic response modifiers per patient with rheumatoid arthritis, psoriasis, psoriatic arthritis, or ankylosing spondylitisMachaon Bonafede, George J Joseph, Nicole Princic, et al.
Journal of Comparative Effectiveness Research|November 19, 2013
Patterns of treatment, healthcare utilization and costs by lines of therapy in metastatic breast cancer in a large insured US populationSaurabh Ray, Vijayveer Bonthapally, Donna McMorrow, et al.
Medical Care|December 29, 2007
The effect of acupuncture utilization on healthcare utilizationMachaon Bonafede, Andrew Dick, Katia Noyes, et al.
Experimental Hematology & Oncology|July 14, 2018
Are patients with high-risk polycythemia vera receiving cytoreductive medications? A retrospective analysis of real-world dataDilan Paranagama, Philomena Colucci, Kristin A Evans, et al.
BMJ Open Diabetes Research & Care|August 23, 2016
Medication usage, treatment intensification, and medical cost in patients with type 2 diabetes: a retrospective database studyMachaon Bonafede, Arthi Chandran, Stefan DiMario, et al.
Journal of Medical Economics|December 23, 2014
Cost per patient-year in response using a claims-based algorithm for the 2 years following biologic initiation in patients with rheumatoid arthritisMachaon Bonafede, Barbara H Johnson, Nicole Princic, et al.
Clinicoeconomics and Outcomes Research : CEOR|May 31, 2021
Real-World Health Care Resource Utilization and Costs Among US Patients with Knee Osteoarthritis Compared with ControlsAngela V Bedenbaugh, Machaon Bonafede, Elizabeth H Marchlewicz, et al.
Journal of Managed Care & Specialty Pharmacy|June 25, 2019
Health Care Utilization and Economic Burden in Patients with Central Precocious Puberty: An Assessment of the Commercially Insured and Medicaid PopulationsKaren Klein, Ahmed M Soliman, Machaon Bonafede, et al.
Neurology and Therapy|February 17, 2020
Care Among Migraine Patients in a Commercially Insured PopulationMachaon Bonafede, Donna McMorrow, Virginia Noxon, et al.
Headache|February 16, 2018
Direct and Indirect Healthcare Resource Utilization and Costs Among Migraine Patients in the United StatesMachaon Bonafede, Sandhya Sapra, Neel Shah, et al.
Pageof 10

Showing results (11-20 of 91) with videos related to

Sort By:
Pageof 10
Journal of Medical Economics|July 2, 2013
Annual acquisition and administration cost of biologic response modifiers per patient with rheumatoid arthritis, psoriasis, psoriatic arthritis, or ankylosing spondylitisMachaon Bonafede, George J Joseph, Nicole Princic, et al.
Journal of Comparative Effectiveness Research|November 19, 2013
Patterns of treatment, healthcare utilization and costs by lines of therapy in metastatic breast cancer in a large insured US populationSaurabh Ray, Vijayveer Bonthapally, Donna McMorrow, et al.
Medical Care|December 29, 2007
The effect of acupuncture utilization on healthcare utilizationMachaon Bonafede, Andrew Dick, Katia Noyes, et al.
Experimental Hematology & Oncology|July 14, 2018
Are patients with high-risk polycythemia vera receiving cytoreductive medications? A retrospective analysis of real-world dataDilan Paranagama, Philomena Colucci, Kristin A Evans, et al.
BMJ Open Diabetes Research & Care|August 23, 2016
Medication usage, treatment intensification, and medical cost in patients with type 2 diabetes: a retrospective database studyMachaon Bonafede, Arthi Chandran, Stefan DiMario, et al.
Journal of Medical Economics|December 23, 2014
Cost per patient-year in response using a claims-based algorithm for the 2 years following biologic initiation in patients with rheumatoid arthritisMachaon Bonafede, Barbara H Johnson, Nicole Princic, et al.
Clinicoeconomics and Outcomes Research : CEOR|May 31, 2021
Real-World Health Care Resource Utilization and Costs Among US Patients with Knee Osteoarthritis Compared with ControlsAngela V Bedenbaugh, Machaon Bonafede, Elizabeth H Marchlewicz, et al.
Journal of Managed Care & Specialty Pharmacy|June 25, 2019
Health Care Utilization and Economic Burden in Patients with Central Precocious Puberty: An Assessment of the Commercially Insured and Medicaid PopulationsKaren Klein, Ahmed M Soliman, Machaon Bonafede, et al.
Neurology and Therapy|February 17, 2020
Care Among Migraine Patients in a Commercially Insured PopulationMachaon Bonafede, Donna McMorrow, Virginia Noxon, et al.
Headache|February 16, 2018
Direct and Indirect Healthcare Resource Utilization and Costs Among Migraine Patients in the United StatesMachaon Bonafede, Sandhya Sapra, Neel Shah, et al.
Pageof 10